GetWiki

{{short description|Chemicals which prevent breakdown of acetylcholine and butyrylcholine}}{{distinguish|Acetylcholinesterase inhibitor|Anticholinergic|Cholinergic}}

factoids

| Consumer_Reports =| medicinenet = cholinesterase_inhibitors| rxlist =}} File:Tetraethyl pyrophosphate.png|thumb|right|250px|Tetraethyl pyrophosphateTetraethyl pyrophosphateCholinesterase inhibitors (ChEIs), also known as anti-cholinesterase, are chemicals that prevent the breakdown of the neurotransmitter acetylcholine or butyrylcholine. This increases the amount of the acetylcholine or butyrylcholine in the synaptic cleft that can bind to muscarinic receptors, nicotinic receptors and others. This group of inhibitors is divided into two subgroups, acetylcholinesterase inhibitors (AChEIs) and butyrylcholinesterase inhibitors (BChEIs).BOOK, English, Brett A., Webster, Andrew A., Primer on the Autonomic Nervous System, Acetylcholinesterase and its Inhibitors, Elsevier, 2012, 978-0-12-386525-0, 10.1016/b978-0-12-386525-0.00132-3, 631–633, BOOK, Deutch, Ariel Y., Roth, Robert H., From Molecules to Networks, Pharmacology and Biochemistry of Synaptic Transmission, Elsevier, 2014, 978-0-12-397179-1, 10.1016/b978-0-12-397179-1.00007-5, 207–237, JOURNAL, Colovic, Mirjana B., Krstic, Danijela Z., Lazarevic-Pasti, Tamara D., Bondzic, Aleksandra M., Vasic, Vesna M., Acetylcholinesterase Inhibitors: Pharmacology and Toxicology, Current Neuropharmacology, Bentham Science Publishers Ltd., 11, 3, 2013-04-01, 1570-159X, 24179466, 3648782, 10.2174/1570159x11311030006, 315–335, ChEIs may be used as drugs for Alzheimer’s and myasthenia gravis, and also as chemical weapons and insecticides.WEB, Cholinesterase Inhibitors (Medical Use & WMD),tmedweb.tulane.edu/pharmwiki/doku.php/cholinesterase_inhibitors_-_medical_use_wmd, PharmWiki, Tulane University School of Medicine, 24 August 2020, JOURNAL, Mandour, Raafat, Environmental Risks of Insecticides Cholinesterase Inhibitors, Toxicology International, 2013, 20, 1, 30–34, United States National Library of Medicine, 10.4103/0971-6580.111556, 23833435, 3702124, free, Side effects when used as drugs may include loss of appetite, nausea, vomiting, loose stools, vivid dreams at night, dehydration, rash, bradycardia, peptic ulcer disease, seizures, weight loss, rhinorrhea, salivation, muscle cramps, and fasciculations.BOOK, Budson, Andrew E., Solomon, Paul R., Memory Loss, Alzheimer’s Disease, and Dementia, Cholinesterase Inhibitors, Elsevier, 2016, 978-0-323-28661-9, 10.1016/b978-0-323-28661-9.00016-0, 160–173, JOURNAL, Khoury, Rita, Rajamanickam, Jayashree, Grossberg, George T., An update on the safety of current therapies for Alzheimer’s disease: focus on rivastigmine, Therapeutic Advances in Drug Safety, SAGE Publications, 9, 3, 2018-01-08, 2042-0986, 29492246, 5810854, 10.1177/2042098617750555, 171–178, ChEIs are indirect-acting parasympathomimetic drugs.BOOK, Forrester, John V., Dick, Andrew D., McMenamin, Paul G., Roberts, Fiona, Pearlman, Eric, The Eye, General and ocular pharmacology, Elsevier, 2016, 978-0-7020-5554-6, 10.1016/b978-0-7020-5554-6.00006-x, 338–369.e1, Parasympathomimetics are a group of drugs that act either by directly stimulating the muscarinic receptor, for example pilocarpine, or by inhibiting the enzyme acetylcholinesterase, which hydrolyses the acetylcholine in the synapse., ChEls are widely used as chemical weapons. Since November 2019 the group of ACheIs known as Novichoks have been banned as agents of warfare under the Chemical Weapons Convention.JOURNAL, 10.1038/d41586-019-03686-y, Novichok nerve agents banned by chemical-weapons treaty, 2019, Castelvecchi, Davide, Nature, 33244185, Novichok agents are neurotoxic organophosphorus compounds and are considered more potent than VX gas, also a neurotoxic organophosphorus compound.JOURNAL, 10.1080/24734306.2018.1475151, Novichok agents: A historical, current, and toxicological perspective, 2018, Chai, Peter R., Hayes, Bryan D., Erickson, Timothy B., Boyer, Edward W., Toxicology Communications, 2, 1, 45–48, 30003185, 6039123,

Medical use

{{further|Donepezil#Medical uses}}While 4 ChEIs are approved in the US for the treatment of Alzheimer’s Disease, only three of these are available commercially. The three available are rivastigmine, donepezil, and galantamine, while tacrine is not. They are generally used to treat Alzheimer’s disease and dementia. If a benefit occurs, it is generally during the second or third month after starting.It is difficult to determine which ChEI has greater efficacy, due to design flaws in head-to-head comparison studies.Pyridostigmine is used in the treatment of myasthenia gravis.BOOK, WHO Model Formulary 2008, 2009, 9789241547659, ((World Health Organization)), Stuart MC, Kouimtzi M, Hill SR, 10665/44053, World Health Organization, World Health Organization, 429, Neostigmine is used in combination with a muscarinic antagonist to reverse the effects of non-depolarizing muscle relaxants e.g. rocuronium bromide

Cholinesterase inhibitor toxicity

{{See|Organophosphate poisoning|cholinergic crisis}}Common side effects of one ChEI include insomnia, nausea and vomiting, accidental injury, headache, dizziness, bradycardia, hypotension, ecchymosis, and sleep disturbance.WEB, 2012, Prescribing information : Aricept,www.accessdata.fda.gov/drugsatfda_docs/label/2012/020690s035,021720s008,022568s005lbl.pdf, live, 6 May 2021, FDA access data, Eisai Inc. and Pfizer Inc.,www.accessdata.fda.gov:80/drugsatfda_docs/label/2012/020690s035,021720s008,022568s005lbl.pdf," title="web.archive.org/web/20160221204009www.accessdata.fda.gov:80/drugsatfda_docs/label/2012/020690s035,021720s008,022568s005lbl.pdf,">web.archive.org/web/20160221204009www.accessdata.fda.gov:80/drugsatfda_docs/label/2012/020690s035,021720s008,022568s005lbl.pdf, 2016-02-21,

Binding affinity

Acetylcholinesterase inhibitors

Donepezil, phenserine, huperzine A, and BW284c51 are selective AChE inhibitors.BOOK, Waiskopf, Nir, Soreq, Hermona, Handbook of Toxicology of Chemical Warfare Agents, Cholinesterase Inhibitors, Elsevier, 2015, 978-0-12-800159-2, 10.1016/b978-0-12-800159-2.00052-x, 761–778, BOOK, Hersen, Michel, Comprehensive handbook of personality and psychopathology,archive.org/details/comprehensivehan02hers, limited, John Wiley, Hoboken, New Jersey, 2006, 978-0-471-75725-2, 63041762, 514, Tertiary source,

Butyrylcholinesterase inhibitor

Tetra (monoisopropyl) pyrophosphoramide (Iso-OMPA) and ethopropazine are selective BChE inhibitors.

AChE and BChE inhibitor

Paraoxon and rivastigmine are both acetylcholinesterase inhibitors and butyrylcholinesterase inhibitors.In 2015, the United States Food and Drug Administration’s Adverse Event Reporting System database compared rivastigmine to the other ChEI drugs donepezil and galantamine found that rivastigmine was associated with a higher frequency of reports of death as an adverse event.JOURNAL, Ali TB, Schleret TR, Reilly BM, Chen WY, Abagyan R, Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada, PLOS ONE, 10, 12, e0144337, 2015, 26642212, 4671709, 10.1371/journal.pone.0144337, 2015PLoSO..1044337A, free,

Acetylcholinesterase inhibitors and nicotinic receptor modulator

{{see also|Allosteric modulator|nicotinic receptor}}Galantamine might be less well tolerated than donepezil and rivastigmine.

Chemical weapons

{{Further|Chemical weapon}}

Assassination Attempt

Cholinesterase inhibitors came to a public attention in 2020 when Russian opposition and dissent figure Alexei Navalny was treated in Berlin Charité hospital for poisoning by a Russian-made nerve agent which is known since 2019 as belonging to the Novichok agents subgroup of ChEI.NEWS, 2 September 2020, Alexei Navalny was poisoned ‘using Novichok’ nerve agent, say German government, Telegraph Media Group Limited,www.telegraph.co.uk/news/2020/09/02/alexei-navalny-poisoned-using-novichok-nerve-agent-say-german/,

See also

• Organophosphate and carbamate

Further reading

• BOOK, Institute, National, (UK), Care Excellence, Cholinesterase inhibitors and memantine for dementia, NCBI Bookshelf, 2019-12-27,www.ncbi.nlm.nih.gov/books/NBK536484/, 2019-12-27,
• JOURNAL, Parsons, Chris G., Danysz, Wojciech, Dekundy, Andrzej, Pulte, Irena, Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease, Neurotoxicity Research, Springer Science and Business Media LLC, 24, 3, 2013-05-09, 1029-8428, 23657927, 3753463, 10.1007/s12640-013-9398-z, 358–369,
• JOURNAL, Meng, Yan‑Hong, Wang, Pan‑Pan, Song, Ya‑Xue, Wang, Jian‑Hua, Cholinesterase inhibitors and memantine for Parkinson’s disease dementia and Lewy body dementia: A meta‑analysis, Experimental and Therapeutic Medicine, 17, 3, 2019-03-01, 1792-0981, 10.3892/etm.2018.7129, 1611–1624, 30783428, 6364145,www.spandidos-publications.com/etm/17/3/1611, 2019-12-27, free,

References

{{reflist}}{{Pharmacomodulation}}